Sign in

CIK 0001280776

  • Non-accelerated filer
  • Smaller reporting company

IMMUNIC, INC.

Sign in to watch
Ticker
IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562358443
Phone
+1 332-255-9818
Business address
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
Former names
VITAL THERAPIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-01-11 Swanson Michael V. Chief Financial Officer, EVP Returned to the company · Stock Option (right to buy) −90,000 0
2019-01-11 Swanson Michael V. Chief Financial Officer, EVP Returned to the company · Stock Option (right to buy) −75,000 0
2019-01-11 Swanson Michael V. Chief Financial Officer, EVP Returned to the company · Stock Option (right to buy) −75,000 0
2019-01-11 Swanson Michael V. Chief Financial Officer, EVP Returned to the company · Stock Option (right to buy) −75,000 0
2019-01-11 Swanson Michael V. Chief Financial Officer, EVP Grant or award · Restricted Stock Units +817,826 817,826
2018-06-09 Swanson Michael V. Chief Financial Officer, EVP Grant or award · Stock Option (right to buy) +75,000 75,000
2017-06-10 Swanson Michael V. Chief Financial Officer, EVP Grant or award · Stock Option (right to buy) +75,000 75,000
2016-05-13 Swanson Michael V. Grant or award · Stock Option (right to buy) +75,000 75,000

Page 1 of 1 · 8 trades